PH17017A - Process for preventing degradation of acid salts of thieno-pyridine derivatives - Google Patents

Process for preventing degradation of acid salts of thieno-pyridine derivatives

Info

Publication number
PH17017A
PH17017A PH25971A PH25971A PH17017A PH 17017 A PH17017 A PH 17017A PH 25971 A PH25971 A PH 25971A PH 25971 A PH25971 A PH 25971A PH 17017 A PH17017 A PH 17017A
Authority
PH
Philippines
Prior art keywords
thieno
acid salts
pyridine derivatives
preventing degradation
acid
Prior art date
Application number
PH25971A
Other languages
English (en)
Inventor
Zaka Ud-Din T Chowhan
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22631437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH17017(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PH17017A publication Critical patent/PH17017A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
PH25971A 1980-07-29 1981-07-28 Process for preventing degradation of acid salts of thieno-pyridine derivatives PH17017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17331080A 1980-07-29 1980-07-29

Publications (1)

Publication Number Publication Date
PH17017A true PH17017A (en) 1984-05-11

Family

ID=22631437

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25971A PH17017A (en) 1980-07-29 1981-07-28 Process for preventing degradation of acid salts of thieno-pyridine derivatives

Country Status (16)

Country Link
EP (1) EP0045238B1 (fr)
JP (1) JPS5753414A (fr)
AT (1) ATE22530T1 (fr)
AU (1) AU546492B2 (fr)
CA (1) CA1176170A (fr)
DE (1) DE3175410D1 (fr)
DK (1) DK159590C (fr)
GB (1) GB2080683B (fr)
GR (1) GR74953B (fr)
IE (1) IE51419B1 (fr)
IL (1) IL63315A (fr)
NO (1) NO157643C (fr)
NZ (1) NZ197783A (fr)
PH (1) PH17017A (fr)
PT (1) PT73442B (fr)
ZA (1) ZA814950B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
JPH075464B2 (ja) * 1985-07-08 1995-01-25 中外製薬株式会社 安定なニコランジル製剤
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
KR950010150B1 (ko) * 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
US5684121A (en) * 1994-12-06 1997-11-04 Isp Investments Inc. N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
EP1005864A1 (fr) * 1998-11-30 2000-06-07 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Compositions pharmaceutiques stables dépourvues d'antioxidant contenant des dérivés thiènopyridine
FR2789589A1 (fr) * 1999-02-16 2000-08-18 Igen Procede de conditionnement de compositions pharmaceutiques et compositions de ticlopidine obtenues par ce procede.
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
WO2011052499A1 (fr) * 2009-10-28 2011-05-05 第一三共株式会社 Composition pharmaceutique présentant une stabilité au stockage améliorée
WO2017131001A1 (fr) * 2016-01-25 2017-08-03 サントリーホールディングス株式会社 Composition comprenant une capsule en gélatine d'acide ellagique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585778A (fr) * 1958-04-18
DE2157201C3 (de) * 1970-11-13 1974-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verbesserte feste orale Applikationsform von Raubasin
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
GB1498857A (en) * 1975-07-03 1978-01-25 Leo Ab Antidepressant composition
FR2358150A1 (fr) * 1976-07-13 1978-02-10 Parcor Nouvelles thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application

Also Published As

Publication number Publication date
EP0045238A2 (fr) 1982-02-03
NO157643B (no) 1988-01-18
GB2080683A (en) 1982-02-10
GR74953B (fr) 1984-07-12
DK159590B (da) 1990-11-05
NO157643C (no) 1988-04-27
GB2080683B (en) 1984-09-19
AU7351881A (en) 1982-09-23
IE51419B1 (en) 1986-12-24
DK159590C (da) 1991-04-08
DK321081A (da) 1982-01-30
CA1176170A (fr) 1984-10-16
AU546492B2 (en) 1985-09-05
EP0045238B1 (fr) 1986-10-01
DE3175410D1 (en) 1986-11-06
JPH0243725B2 (fr) 1990-10-01
IL63315A (en) 1984-03-30
PT73442B (en) 1983-02-16
IL63315A0 (en) 1981-10-30
IE811650L (en) 1982-01-29
JPS5753414A (en) 1982-03-30
ZA814950B (en) 1982-08-25
PT73442A (en) 1981-08-01
NZ197783A (en) 1984-03-30
EP0045238A3 (en) 1983-02-16
ATE22530T1 (de) 1986-10-15
NO812556L (no) 1982-02-01

Similar Documents

Publication Publication Date Title
PH17017A (en) Process for preventing degradation of acid salts of thieno-pyridine derivatives
AU7607991A (en) Method of inhibiting gastric acid secretion
RU92016595A (ru) Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
AU552998B2 (en) Ursolic acid derivatives
GR3020190T3 (en) Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it
ES8302623A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".
JPS56118062A (en) 44aryloxy and 44arylthioo33phenylpiperidine derivative
AU555496B2 (en) Phenoxypyridine ffor normalizing hippocampal function
ES2006882A6 (es) Procedimiento para la preparacion de acidos quinolincarboxilicos.
ES535408A0 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
EP0415564A3 (en) Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivaties
IT1247983B (it) Derivati di una pirrolo-piridina, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
DK34882A (da) Fremgangsmaade til fremstilling af peptidderivater
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
JPS5225008A (en) Hoof protecting drug
ES8302624A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxiacetico".
ES473070A1 (es) Procedimiento para la obtencion de 2,3,4,7,8.9-octahidropi- razinopirimidinonas substituidas